Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · IEX Real-Time Price · USD
26.07
-0.03 (-0.11%)
Apr 19, 2024, 10:09 AM EDT - Market open
Pacira BioSciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 674.98 | 666.82 | 541.53 | 429.65 | 421.03 | 337.28 | 286.63 | 276.37 | 249 | 197.67 | Upgrade
|
| Revenue Growth (YoY) | 1.22% | 23.14% | 26.04% | 2.05% | 24.83% | 17.67% | 3.71% | 10.99% | 25.97% | 131.05% | Upgrade
|
| Cost of Revenue | 184.67 | 199.3 | 140.26 | 117.33 | 106.71 | 86.85 | 87.92 | 110.1 | 71.84 | 77.44 | Upgrade
|
| Gross Profit | 490.31 | 467.53 | 401.28 | 312.32 | 314.31 | 250.43 | 198.72 | 166.27 | 177.16 | 120.23 | Upgrade
|
| Selling, General & Admin | 269.44 | 254.52 | 199.35 | 193.52 | 200.78 | 177.27 | 161.49 | 152.61 | 139.04 | 106.66 | Upgrade
|
| Research & Development | 76.26 | 84.8 | 55.55 | 59.42 | 72.12 | 55.69 | 57.29 | 45.68 | 28.66 | 18.73 | Upgrade
|
| Other Operating Expenses | 56.94 | 68.19 | 56.46 | 13.03 | 30.93 | 1.56 | 4.87 | 0 | 0 | 0 | Upgrade
|
| Operating Expenses | 402.63 | 407.5 | 311.35 | 265.97 | 303.83 | 234.52 | 223.65 | 198.29 | 167.71 | 125.39 | Upgrade
|
| Operating Income | 87.68 | 60.02 | 89.92 | 46.35 | 10.48 | 15.92 | -24.94 | -32.02 | 9.46 | -5.17 | Upgrade
|
| Interest Expense / Income | 20.31 | 39.98 | 31.75 | 25.67 | 23.63 | 21.95 | 18.05 | 7.06 | 7.73 | 8.28 | Upgrade
|
| Other Expense / Income | 5.67 | 6.75 | 1.77 | 0.59 | -2.4 | -5.61 | -0.51 | -1.24 | -0.39 | 0.1 | Upgrade
|
| Pretax Income | 61.7 | 13.3 | 56.4 | 20.09 | -10.75 | -0.43 | -42.47 | -37.84 | 2.12 | -13.54 | Upgrade
|
| Income Tax | 19.75 | -2.61 | 14.42 | -125.43 | 0.27 | 0.05 | 0.14 | 0.11 | 0.26 | 0.17 | Upgrade
|
| Net Income | 41.96 | 15.91 | 41.98 | 145.52 | -11.02 | -0.47 | -42.61 | -37.95 | 1.86 | -13.72 | Upgrade
|
| Net Income Growth | 163.72% | -62.10% | -71.15% | - | - | - | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 46 | 46 | 44 | 43 | 42 | 41 | 40 | 37 | 37 | 35 | Upgrade
|
| Shares Outstanding (Diluted) | 52 | 47 | 46 | 44 | 42 | 41 | 40 | 37 | 41 | 35 | Upgrade
|
| Shares Change | 11.69% | 1.99% | 4.46% | 5.22% | 1.47% | 2.78% | 6.90% | -9.84% | 17.00% | 6.38% | Upgrade
|
| EPS (Basic) | 0.91 | 0.35 | 0.95 | 3.41 | -0.27 | -0.01 | -1.07 | -1.02 | 0.05 | -0.39 | Upgrade
|
| EPS (Diluted) | 0.89 | 0.34 | 0.92 | 3.33 | -0.27 | -0.01 | -1.07 | -1.02 | 0.04 | -0.39 | Upgrade
|
| EPS Growth | 161.76% | -63.04% | -72.37% | - | - | - | - | - | - | - | Upgrade
|
| Free Cash Flow | 139.49 | 115.2 | 79.85 | 39.23 | 60.36 | 34.36 | -1.48 | 8.74 | -12.27 | 3.58 | Upgrade
|
| Free Cash Flow Per Share | 3.02 | 2.53 | 1.80 | 0.92 | 1.45 | 0.84 | -0.04 | 0.23 | -0.34 | 0.10 | Upgrade
|
| Gross Margin | 72.64% | 70.11% | 74.10% | 72.69% | 74.65% | 74.25% | 69.33% | 60.16% | 71.15% | 60.82% | Upgrade
|
| Operating Margin | 12.99% | 9.00% | 16.61% | 10.79% | 2.49% | 4.72% | -8.70% | -11.59% | 3.80% | -2.61% | Upgrade
|
| Profit Margin | 6.22% | 2.39% | 7.75% | 33.87% | -2.62% | -0.14% | -14.87% | -13.73% | 0.75% | -6.94% | Upgrade
|
| Free Cash Flow Margin | 20.67% | 17.28% | 14.75% | 9.13% | 14.34% | 10.19% | -0.52% | 3.16% | -4.93% | 1.81% | Upgrade
|
| Effective Tax Rate | 32.00% | -19.60% | 25.57% | -624.39% | - | - | - | - | 12.45% | - | Upgrade
|
| EBITDA | 157.58 | 144.78 | 116.7 | 65.67 | 32.46 | 34.69 | -10.59 | -17.86 | 21.32 | 4.77 | Upgrade
|
| EBITDA Margin | 23.35% | 21.71% | 21.55% | 15.28% | 7.71% | 10.29% | -3.70% | -6.46% | 8.56% | 2.41% | Upgrade
|
| Depreciation & Amortization | 75.57 | 91.5 | 28.55 | 19.91 | 19.58 | 13.17 | 13.83 | 12.92 | 11.48 | 10.04 | Upgrade
|
| EBIT | 82.01 | 53.28 | 88.15 | 45.76 | 12.88 | 21.52 | -24.42 | -30.78 | 9.85 | -5.27 | Upgrade
|
| EBIT Margin | 12.15% | 7.99% | 16.28% | 10.65% | 3.06% | 6.38% | -8.52% | -11.14% | 3.95% | -2.66% | Upgrade
|